scholarly article | Q13442814 |
P2093 | author name string | Beck JC | |
West D | |||
John EM | |||
Beiswanger CM | |||
Satariano E | |||
P433 | issue | 5 | |
P921 | main subject | epidemiology | Q133805 |
P304 | page(s) | 551-554 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies | |
P478 | volume | 10 |
Q40366644 | A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines |
Q38694903 | Application of Epstein-Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
Q36282672 | Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes |
Q39895402 | Capacity of robot handling for Epstein-Barr virus transformation |
Q37396256 | Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. |
Q37608236 | Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing |
Q36976975 | Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing |
Q30227504 | Development of genomic DNA reference materials for genetic testing of disorders common in people of Ashkenazi jewish descent |
Q37164451 | Development of genomic reference materials for cystic fibrosis genetic testing |
Q33974258 | Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR |
Q40302820 | Efficient and reliable establishment of lymphoblastoid cell lines by Epstein-Barr virus transformation from a limited amount of peripheral blood |
Q35870313 | Establishment of Stably EBV-Transformed Cell Lines from Residual Clinical Blood Samples for Use in Performance Evaluation and Quality Assurance in Molecular Genetic Testing |
Q40207759 | High-potentiality preliminary selection criteria and transformation time-dependent factors analysis for establishing Epstein-Barr virus transformed human lymphoblastoid cell lines |
Q37304493 | Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines |
Q36125233 | National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China |
Q24598264 | Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY |
Q34381762 | Population Differences in the Rate of Proliferation of International HapMap Cell Lines |
Q33302400 | Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension |
Q35083512 | Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel |
Q35172462 | Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells |
Q95797689 | SOD2 polymorphisms: unmasking the effect of polymorphism on splicing |
Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
Q30446682 | The Siblings With Ischemic Stroke Study (SWISS): a progress report |
Q23920041 | XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study |
Search more.